North America

Mon
13
Apr

Anxiety and COVID-19: Can CBD Help?

Times are difficult. People are under a lot of stress, and no one can say with any certainty how long this pandemic is going to last.

Even if you’re not generally anxious, you have every right to be a little freaked out in a situation like this.

One of the most studied effects of CBD is its ability to act as an anxiolytic, which means that it can be used to battle anxiety.

What’s also important in relation to the coronavirus is that CBD isn’t a psychotropic compound, and it doesn’t alter a person’s mental state, like for instance THC.

Mon
13
Apr

Did COVID-19 Kill The Cannabis Industry’s Merger And Acquisition Activity?

According to new data, the week ending March 20, 2020 saw a nearly 67% decrease in merger and acquisition activity versus the same period in 2019.

In 2019, there were over 290 merger and acquisition transactions in the cannabis industry. We’re now over 3 months into 2020 and there have been just 20 so far, leading many investors to questions whether or not the novel coronavirus has killed the marijuana industry’s M&A streak.

Mon
13
Apr

Cannabis researchers want to take the mystery out of weed. Here's why that's a mistake

I’m always on the hunt for a cannabis strain called Sour Glue. I bought a quarter on the illicit market years ago, and its pungent, gassy-citrus flavours and high-THC punch had heady but not heavy effects. After sharing some with friends, we were quickly cracking deeply silly jokes and cackling our asses off. 

I have no idea if it’s rare, but I haven’t been able to find it since. 

That’s why a story like the New York Times’s latest long-read about weed, Cannabis Scientists Are Chasing The Perfect High, sounded relevant to my interests. “Same,” I thought. 

But this story, and those like it, aren’t really written for people who enjoy getting high.

Mon
13
Apr

How CBG May Revolutionize The Cannabis Industry As 'The Next Big Thing'

First discovered in the 1960s, Cannabigerol (CBG), a once rare, non-psychoactive molecule from which hundreds of other cannabinoids are derived, recently gained momentum as more companies and brands like Avicanna Inc. AVCNF 0.55% learn of the molecule’s therapeutic benefits in over-the-counter and pharmaceutical applications.

According to recent investigations by Avicanna, CBG has similar properties to CBD, acting as a competitive partial agonist for cannabinoid receptors in the nervous system and immune cells.

Mon
13
Apr

Coronavirus & CBD: Navigating Shifts in Consumer Behavior

Aggressive health measures to stem the spread of the Coronavirus or COVID-19 are changing everything, including the operation of CBD businesses.  And if there’s one thing CBD business owners are accustomed to, it’s change.

Mon
13
Apr

No Budtender? No Problem. Picking Perfect Products Online

When there aren’t any budtenders to describe the deal of the day, or offer guidance when choosing between a sativa or an indica, how will customers choose which products to buy? A recent article from Green Entrepreneur claims that nearly 90 percent of purchasing decisions are based on recommendations from budtenders. As dispensaries across the country have been forced to transition to online ordering or delivery due to COVID-19 health concerns, customers are left with a new challenge: how do I pick the right cannabis product for my needs?

Mon
13
Apr

Is the Pandemic Hindering Global Cannabis Research and Innovation?

The cannabis movement and research surrounding the plant now have more momentum than at any other point since prohibition began.

The momentum for cannabis reform efforts and also for innovation in cannabis technology, medicine, and science is carrying the industry forward at a rapid pace.

Thu
09
Apr

Will Marijuana Stocks Start To Rebound Soon?

The coronavirus has caused quite a big stir amongst marijuana stocks. In only a few short weeks, we have watched billions in market value go down the drain. During that time, however, we have also seen demand for cannabis shoot up. This could be attributed to the large portion of individuals staying at home with nothing to do, but it undoubtedly is a good sign. It appears as though the current losses are helping to show that there may be value in some beaten-down pot stocks. This means that we could see more bulls begin to enter the cannabis industry within the next few weeks.

Thu
09
Apr

Is Medical Marijuana a Misnomer in its Current Form?

There is no disputing that cannabis provides medicinal relief to scores of people. However, federal regulations limit the scope of testing for marijuana recommended for patients, unlike the rigorous testing standards held for other medicines. As such, only a few cannabis-esque medicines have been able to reach the U.S. market to date. With a handful of medications and dispensary options to choose from, one could argue that medical cannabis, in its current form, is a misnomer to some degree. 

Thu
09
Apr

The one mistake most new cannabis cooks make

So you’re new to cannabis — welcome! You’ve likely already started enjoying and experimenting (always in moderation). The edibles at your local shop look so yummy, don’t they? But $15 for a brownie?! You’ve been baking your entire life. How tough can it be to make your own?

The answer: It’s not. But it’s likely not the same kind of baking you’re used to. To cook with marijuana properly (meaning effectively, as in, the marijuana doesn’t take over the flavor of the dish completely and it’s the correct dosage), you need to take the step even the most enthusiast “baker” down the street is probably forgetting — decarboxylation.

Pages

Subscribe to RSS - North America